Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127560421 | 12756042 | 1 | I | 2016 | 20160912 | 20160916 | 20160916 | PER | US-PFIZER INC-2016429609 | PFIZER | 63.00 | YR | F | Y | 65.32000 | KG | 20160916 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127560421 | 12756042 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, 1X/DAY | D | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | QD | |||||
127560421 | 12756042 | 2 | C | METOPROLOL. | METOPROLOL | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
127560421 | 12756042 | 3 | C | METOPROLOL. | METOPROLOL | 1 | 25 MG, UNK | 0 | 25 | MG | |||||||||
127560421 | 12756042 | 4 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 125 UG, UNK | 0 | 125 | UG | |||||||||
127560421 | 12756042 | 5 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
127560421 | 12756042 | 6 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 40 MG, UNK | 0 | 40 | MG | |||||||||
127560421 | 12756042 | 7 | C | BABY ASPIRIN | ASPIRIN | 1 | 81 MG, UNK | 0 | 81 | MG | |||||||||
127560421 | 12756042 | 8 | C | NASONEX | MOMETASONE FUROATE | 1 | Nasal | 2 PUFFS IN EACH NOSTRIL DAILY | 0 | 2 | DF | ||||||||
127560421 | 12756042 | 9 | C | COENZYME Q10 | UBIDECARENONE | 1 | 100 MG, DAILY | 0 | 100 | MG | |||||||||
127560421 | 12756042 | 10 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 4000 IU, UNK | 3141700 | 0 | 4000 | IU | ||||||||
127560421 | 12756042 | 11 | C | DURAGESIC | FENTANYL | 1 | 100MCG PER HOUR, WEARS THE PATCH FOR THREE DAYS | 0 | |||||||||||
127560421 | 12756042 | 12 | C | MORPHINE | MORPHINE | 1 | 15 MG, AS NEEDED | 0 | 15 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127560421 | 12756042 | 1 | Depression |
127560421 | 12756042 | 2 | Hypertension |
127560421 | 12756042 | 4 | Thyroid mass |
127560421 | 12756042 | 5 | Blood cholesterol increased |
127560421 | 12756042 | 6 | Reflux laryngitis |
127560421 | 12756042 | 7 | Prophylaxis |
127560421 | 12756042 | 8 | Sinus disorder |
127560421 | 12756042 | 9 | Cardiac disorder |
127560421 | 12756042 | 10 | Vitamin D deficiency |
127560421 | 12756042 | 11 | Pain |
127560421 | 12756042 | 12 | Breakthrough pain |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127560421 | 12756042 | Apathy | |
127560421 | 12756042 | Crying | |
127560421 | 12756042 | Depression | |
127560421 | 12756042 | Feeling abnormal | |
127560421 | 12756042 | Pain | |
127560421 | 12756042 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127560421 | 12756042 | 6 | 2016 | 0 | ||
127560421 | 12756042 | 10 | 2007 | 0 |